Your browser doesn't support javascript.
loading
Possible anti-metastatic effect of iloprost in a patient with systemic sclerosis with lung cancer: a case study.
Pehlivan, Yavuz; Turkbeyler, Ibrahim Halil; Balakan, Ozan; Sevinc, Alper; Yilmaz, Mustafa; Bakir, Kemal; Onat, Ahmet Mesut.
Affiliation
  • Pehlivan Y; School of Medicine, Department of Rheumatologyn, Sahinbey Medical Center, Gaziantep University, TR-27310, Gaziantep, Turkey. drpehlivan@hotmail.com
Rheumatol Int ; 32(5): 1437-41, 2012 May.
Article in En | MEDLINE | ID: mdl-21448647

Full text: 1 Database: MEDLINE Main subject: Scleroderma, Systemic / Vasodilator Agents / Adenocarcinoma / Iloprost / Hypertension, Pulmonary / Lung Neoplasms / Antihypertensive Agents / Antineoplastic Agents Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Year: 2012 Type: Article

Full text: 1 Database: MEDLINE Main subject: Scleroderma, Systemic / Vasodilator Agents / Adenocarcinoma / Iloprost / Hypertension, Pulmonary / Lung Neoplasms / Antihypertensive Agents / Antineoplastic Agents Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Year: 2012 Type: Article